BioScience Health Innovations, Inc.
NOTR
$9.01
-$0.99-9.90%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 126.04% | 198.42% | 186.99% | 24.47% | 51.82% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | -- | -- | -- | -- |
| Change in Net Operating Assets | -233.15% | 69.70% | 83.16% | 32.50% | -761.90% |
| Cash from Operations | 10.97% | 174.15% | 160.63% | 28.04% | 30.84% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 5.18% | 55.32% | 73.78% | 215.88% | 113.64% |
| Total Debt Repaid | -31.60% | -18.92% | -122.36% | -1,489.44% | -84.60% |
| Issuance of Common Stock | 1,720.00% | 4.17% | -100.00% | -- | -75.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1,082.79% | 75.73% | -113.54% | 88.39% | -60.68% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,544.30% | 1,517.95% | 144.02% | 3,609.52% | -670.00% |